Search
In response to DNA damaging chemotherapy, targeting MK2 in p53-mutated cells produces a phenotype that is distinct from the p53-deficient phenotype
In this review we explore the current literature about the predictive characteristics of the tumor microenvironment and discuss therapeutic approaches
The aim of our study was to investigate whether CBL0137 has potential as a therapeutic and chemopotentiating compound in MLL-r leukemia
We discovered a previously unknown major resistance mechanism in glioma in that most EGFR domain III-targeting antibodies do not neutralize EGFRvIII
We present a curated panel of 12 readily-usable, cell lines representing the spectrum of molecular subtypes of IDH-wildtype glioblastoma
Bevacizumab is well tolerated and appears most effective for rapid tumor control to preserve vision and improve morbidity
This multi-center study provides valuable information on the success rate of establishing patient-derived pre-clinical models of diffuse intrinsic pontine glioma
These findings provide a compelling argument for efforts to reduce exposure of the brainstem in the treatment of medulloblastoma
Medulloblastoma is a highly malignant small round blue cell tumor of the posterior fossa
This chapter summarizes recent advances in diffuse intrinsic pontine glioma and potential novel therapies